Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jun;111(6):1195-1196.
doi: 10.1002/cpt.2579. Epub 2022 Apr 8.

Lorlatinib Exposed: A Far From Optimal Dose

Affiliations
Free article
Comment

Lorlatinib Exposed: A Far From Optimal Dose

Garth W Strohbehn et al. Clin Pharmacol Ther. 2022 Jun.
Free article
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Chen, J. et al. Lorlatinib exposure-response analyses for safety and efficacy in a phase I/II trial to support benefit-risk assessment in non-small cell lung cancer. Clin. Pharmacol. Ther. 110, 1273-1281 (2021).
    1. Pascual, I. et al. Association of elevated serum triglyceride levels with a more severe course of acute pancreatitis: cohort analysis of 1457 patients. Pancreatology 19, 623-629 (2019).
    1. Camidge, D.R. Lorlatinib should not be considered as the preferred first-line option in patients with advanced ALK rearranged NSCLC. J. Thorac. Oncol. 16, 528-531 (2021).
    1. Ratain, M.J., Tannock, I.F. & Lichter, A.S. Dose optimization of sotorasib: is the US Food and Drug Administration Sending a Message? J. Clin. Oncol. 39, 3423-3426 (2021).
    1. Friends of Cancer Research. Optimizing Dosing in Oncology Drug Development: A Friends of Cancer Research White Paper (Friends of Cancer Research, Washington, DC, 2021).